Artis BioSolutions
Lake Nona, FL
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
59.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (6)
○ EMA GMP
○ MHRA GMP
Quick Facts: Artis BioSolutions
- Signal Score
- 59.0/100 (as of 2026-09-07)
- Quality Compliance
- Assessment pending
- Headquarters
- Lake Nona, FL
- Modalities
- Cell Therapy, CAR-T
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Artis BioSolutions
Pure-play CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, CAR-T
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
58.0
Profile-based capacity assessment
Recent Press6 articles
Recent News 6 articles
Synthetic DNA Manufacturing Hub Set Up in Boston by Artis BioSolutions - Genetic Engineering and Biotechnology News
Synthetic DNA Manufacturing Hub Set Up in Boston by Artis BioSolutions Genetic Engineering and Biotechnology News
Artis BioSolutions Establishes Synthetic DNA Mfg. Hub in Boston - Contract Pharma
Artis BioSolutions Establishes Synthetic DNA Mfg. Hub in Boston Contract Pharma
Artis BioSolutions Expands with New Synthetic DNA Manufacturing Capabilities in Boston - citybiz
Artis BioSolutions Expands with New Synthetic DNA Manufacturing Capabilities in Boston citybiz
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston - Business Wire
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston Business Wire
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston - Yahoo Finance
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston Yahoo Finance
Artis BioSolutions Appoints Dr. Kate Broderick, Ph.D., as Chief Scientific Innovation Officer to Advance Synthetic DNA Strategy - Business Wire
Artis BioSolutions Appoints Dr. Kate Broderick, Ph.D., as Chief Scientific Innovation Officer to Advance Synthetic DNA Strategy Business Wire
Frequently Asked Questions About Artis BioSolutions
What is Artis BioSolutions's CDMO Signal Score?
Artis BioSolutions has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating Artis BioSolutions for a manufacturing program?
Use the free AI matchmaker to compare Artis BioSolutions against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 91.1
CAR-T, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.9
CAR-T, Cell Therapy
Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.3
CAR-T, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 82.9
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody